Protéines recombinantes
Protéines modifiées ou manipulées codées par l'ADN recombinant et adaptées à divers usages, notamment la modification de séquences génétiques, la production massive de protéines et la fabrication de produits commerciaux.
À utiliser avec (application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,091)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (40)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,065)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,629)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (41)
- (255)
- (159)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,338)
- (25)
- (3)
- (30)
- (14)
- (10)
- (72)
- (13)
- (78)
- (77)
- (34)
- (1)
- (13)
- (1)
- (1,155)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,641)
- (2,890)
- (4)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,317)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (11)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,021)
- (1,863)
- (1)
- (1)
Conjugué
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,860)
Recombinant
- (58)
- (34,768)
Forme
- (1)
- (23,073)
- (9,214)
- (29)
- (146)
- (24)
- (35)
Statut réglementaire
- (75)
- (30,540)
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Rechercher dans les résultats
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
40,101
résultats
Invitrogen™ Vaccinia Virus B18R (Carrier-Free) Recombinant Protein, eBioscience™
Recombinant Protein
| Plage de pH | 7.5 |
|---|---|
| Poids moléculaire (g/mol) | 48 kDa |
| Séquence | Vaccinia Virus B18R, ammino acids His20-Glu351 (Accession # D01019) with a His-tag |
| Type de produit | Protein |
| Concentration en endotoxines | <0.01 ng/μg |
| Activité biologique | Pre-incubation of recombinant IFN-alpha 2 A with 0.1 μg/mL B18R for 1 hour (at RT was found to completely neutralize the activity of 1 ng/mL IFN-alpha 2 a.) |
| Sous-type de protéine | Recombinant |
| Conjugué | Unconjugated |
| Espèces | Bovine,Human,Mouse,Pig,Rabbit,Rat |
| Concentration | 0.5 mg/mL |
| Sources | Vaccinia Virus |
| Nom | Vaccinia Virus B18R (Carrier-Free) |
| Forme | Liquid |
| Contenu et stockage | -80°C |
| Symbole de gène | Vaccinia Virus-Encoded Neutralizing Type I Interferon Receptor; Type I IFN inhibitor |
| Nom usuel | Vaccinia Virus B18R |
| À utiliser avec (application) | Bioactivity,Functional Assay |
| Grade de qualité ou de pureté | >98% by SDS-PAGE |
| Système d’expression | Insect cells |
| Méthode de purification | Purified |
| Étiquette de la protéine | His-tag |
| Durée de conservation | 12 Months |
| Formule | PBS with no preservative; pH 7.5 |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 26.9 kDa |
|---|---|
| Numéro d'enregistrement | Q9BXY4 |
| Séquence | MHPNVSQGCQ GGCATCSDYN GCLSCKPRLF FALERIGMKQ IGVCLSSCPS GYYGTRYPDI NKCTKCKADC DTCFNKNFCT KCKSGFYLHL GKCLDNCPEG LEANNHTMEC VSIVHCEVSE WNPWSPCTKK GKTCGFKRGT ETRVREIIQH PSAKGNLCPP TNETRKCTVQ RKKCQKGERG KKGRERKRKK PNKGESKEAI PDSKSLESSK EIPEQRENKQ QQKKRKVQDK QKSVSVSTVH |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | R-Spondin-3 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 for this effect is 0.8 -2.0 ug/ml |
| Conjugué | Unconjugated |
| Sources | CHO cells |
| Nom | Human R-Spondin-3 |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | RSPO3 |
| Nom usuel | RSPO3 |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | 2810459H04Rik; AW742308; Cabriolet; cristin 1; Cristin1; cristin-1; cysteine-rich and single thrombospondin domain-containing protein 1; hPWTSR; hRspo3; Nucleopondin; protein with TSP type-1 repeat; PWTSR; RGD1563246; Roof plate-specific spondin-3; Rspo3; R-spondin 3; R-spondin 3 homolog; R-spondin 3 homolog (Xenopus laevis); R-spondin 3-like protein; R-spondin-3; Thrombospondin type-1 domain-containing protein 2; thrombospondin, type I, domain 2; thrombospondin, type I, domain containing 2; Thsd2; Unknown (protein for MGC:137973) |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | CHO cells |
| ID du gène (Entrez) | 84870 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17.9 kDa |
|---|---|
| Numéro d'enregistrement | P48023 |
| Séquence | HHHHHHHHPS PPPEKKELRK VAHLTGKSNS RSMPLEWEDT YGIVLLSGVK YKKGGLVINE TGLYFVYSKV YFRGQSCNNL PLSHKVYMRN SKYPQDLVMM EGKMMSYCTT GQMWARSSYL GAVFNLTSAD HLYVNVSELS LVNFEESQTF FGLYKL |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by its ability to induce cytotoxicity in Jurkat cells in the absence of any cross-linking. The ED50 for this effect is = 10.0 ng/ml, corresponding to a specific activity of = 1 x 10^5 units/mg |
| Conjugué | Unconjugated |
| Sources | CHO cells |
| Nom | Human Fas Ligand (soluble) |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Faslg |
| Nom usuel | Fas Ligand (CD178) |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | ADAM10-processed FasL form; ALPS1B; APL; Apoptosis (APO 1) antigen ligand 1; apoptosis (APO-1) antigen ligand 1; Apoptosis (APO-1) antigen ligand 1 (Fas antigen ligand); apoptosis antigen ligand; APT1LG1; APTL; CD178; CD178 antigen; CD95 ligand; CD95 ligand protein;Generalized lymphoproliferative disease (Gld); Cd95l; CD95-L; CD95L protein; fas antigen ligand; Fas ligand; Fas ligand (TNF superfamily, member 6); Fasl; Fas-L; FasL ICD; FasL intracellular domain; Faslg; Fas-LG; generalized lymphoproliferative disease; gld; mutant tumor necrosis factor family member 6; Receptor-binding FasL ectodomain; sFasL; Soluble Fas ligand; soluble form; SPA; SPPL2A-processed FasL form; TNFL; Tnfsf6; TNLG1A; Tumor necrosis factor (ligand) superfamily member 6; Tumor necrosis factor (ligand) superfamily member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); Tumor necrosis factor (ligand) superfamily, member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); Tumor necrosis factor ligand; tumor necrosis factor ligand 1A; tumor necrosis factor ligand superfamily member 6; Tumor necrosis factor ligand superfamily member 6 (TNFL6 / TNFSF6); Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | CHO cells |
| ID du gène (Entrez) | 356 |
| Étiquette de la protéine | His-tag |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
